M. Bernard, Pharmacologie des médicaments anxiolytiques et hypnotiques

L. Prescrire and . Accès, Petit manuel de Pharmacovigilance : 1.2 -Profils d'effets indésirables de médicaments psychotropes

J. Fastbom, Y. Forsell, B. Winblad, and . .. Benzodiazepines-may-have-protecti, Alzheimer Dis Assoc Disord, 1998.

H. Amieva, H. Jacqmin-gadda, J. Orgogozo, L. Carret, N. Helmer et al., The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study, Brain, vol.128, issue.5, pp.1093-101, 2005.
DOI : 10.1093/brain/awh451

H. Amieva, L. Goff, M. Millet, X. Orgogozo, J. Peres et al., Prodromal Alzheimer's disease: Successive emergence of the clinical symptoms, Annals of Neurology, vol.79, issue.5, pp.492-500, 2008.
DOI : 10.1002/ana.21509

M. Elias, A. Beiser, P. Wolf, R. Au, R. White et al., The Preclinical Phase of Alzheimer Disease, Archives of Neurology, vol.57, issue.6, pp.808-821, 2000.
DOI : 10.1001/archneur.57.6.808

R. Lagnaoui and B. Bégaud, Benzodiazepine use and risk of dementia: A nested case?control study, pp.1-1864804

R. Lagnaoui, The risk of cognitive impairment in older community-dwelling women after benzodiazepine use, Disponible sur, 2009.
DOI : 10.1093/ageing/afn277

W. .. Cs, The association between dementia and, Am J Geriatr Psychiatry, 2009.

W. Cs, Effect of benzodiazepine discontinuation on dementia risk, 20808131.

J. Gallacher, Benzodiazepine use and risk of dementia: evidence from the Caerphilly Prospective Study (CaPS), Journal of Epidemiology and Community Health, vol.66, issue.10
DOI : 10.1136/jech-2011-200314

S. Billioti-de-gage and B. Begaud, Benzodiazepine use and risk of dementia: prospective population based study, BMJ, vol.345, issue.sep27 4
DOI : 10.1136/bmj.e6231

. Billioti-de-gage, Benzodiazepine use and risk of Alzheimer's disease: case-control study, BMJ, vol.349, issue.sep09 2, 2014.
DOI : 10.1136/bmj.g5205

. Pérès, Health and aging in elderly farmers: the AMI cohort, Disponible sur, pp.1471-2458558, 2012.

T. Antérion, C. Ribas, C. Honoré-masson, and S. , Le questionnaire de plainte cognitive (QPC) : un outil de recherche de plainte suspecte d'évoquer une maladie, Alzheimer, issue.17, pp.56-65, 2003.

M. «. Folstein, ???Mini-mental state???, Journal of Psychiatric Research, vol.12, issue.3, pp.189-98, 1975.
DOI : 10.1016/0022-3956(75)90026-6

E. Grober, H. Buschke, and H. Crystal, Screening for dementia by memory testing, Neurology, vol.38, issue.6, pp.900-903, 1988.
DOI : 10.1212/WNL.38.6.900

D. Wechler, Manual for the Wechsler Adult Intelligence Scale-Revised, 1981.

E. Barbeau, Evaluation of visual recognition memory in MCI patients, Neurology, vol.62, issue.8, p.222226, 1994.
DOI : 10.1212/01.WNL.0000120548.24298.DB

B. Isaacs and A. Akhtar, THE SET TEST: A RAPID TEST OF MENTAL FUNCTION IN OLD PEOPLE, Age and Ageing, vol.1, issue.4, pp.222-228, 1972.
DOI : 10.1093/ageing/1.4.222

J. Nelson and D. Devanand, A Systematic Review and Meta-Analysis of Placebo-Controlled Antidepressant Studies in People with Depression and Dementia, Journal of the American Geriatrics Society, vol.7, issue.(S
DOI : 10.1111/j.1532-5415.2011.03355.x

A. Maladie, Choix d'une benzodiazépine dans les troubles anxieux ou les troubles du sommeil chez le sujet de plus de 65 ans polypathologique ou de plus de 75 ans, 2012.

S. Oui, quelles ont été les conditions d'arrêt du traitement ? 1 /__/ A l'aide d'un médecin 2